0 Commenti
0 condivisioni
629 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
From Gene to Therapy: How Recombinant Protein Production and Protein Expression Systems Are Revolutionizing BiologicsThe creation of a biopharmaceutical is a journey of remarkable scientific and engineering prowess, beginning with the identification of a therapeutic target and culminating in the large-scale manufacture of a lifesaving drug. Central to this journey is Recombinant protein production , a multi-step process that involves inserting a gene encoding a desired protein into a host cell,...0 Commenti 0 condivisioni 474 Views 0 Anteprima
-
Biologics Contract Development and Manufacturing Organization (CDMO) Market: Supporting Next-Generation Biopharmaceutical ProductionAccording to the latest report published by Data Bridge Market Research, the Biologics Contract Development and Manufacturing Organization (CDMO) Market CAGR Value The global biologics contract development and manufacturing organization (CDMO) market size was valued at USD 16.61 billion in 2024 and is expected to reach USD 38.27 billion by 2032, at...0 Commenti 0 condivisioni 720 Views 0 Anteprima
-
Cell Culture Market Expansion Fueled by Growing Focus on Biologics ProductionCell culture technology has become a fundamental component in drug discovery, vaccine production, cancer research, tissue engineering, and biologics manufacturing. According to market estimates, the Cell Culture Market is expected to reach US$ 61.12 billion by 2031 and is anticipated to register a CAGR of 10.7% during 2025–2031. The global Cell Culture Market Size is witnessing...0 Commenti 0 condivisioni 121 Views 0 Anteprima
-
Large Molecule Drug Substance CDMO Market: Advancements in Biologics ProductionAccording to a new report by Polaris Market Research, the global large molecule drug substance CDMO market was valued at USD 53.79 billion in 2025 and is projected to reach USD 102.36 billion by 2034, expanding at a CAGR of 7.41% over the forecast period. Growt0068 is underpinned by rising global approvals of biologic drugs, increasing healthcare expenditure, and accelerating adoption...0 Commenti 0 condivisioni 679 Views 0 Anteprima
-
Large Molecule Drug Substance CDMO Market: Advancements in Biologics ProductionAccording to a new report by Polaris Market Research, the global large molecule drug substance CDMO market was valued at USD 53.79 billion in 2025 and is projected to reach USD 102.36 billion by 2034, expanding at a CAGR of 7.41% over the forecast period. Growt0068 is underpinned by rising global approvals of biologic drugs, increasing healthcare expenditure, and accelerating adoption...0 Commenti 0 condivisioni 660 Views 0 Anteprima
-
Protein A Resin Market Outlook: Advancements in Bioprocessing, Purification Technologies, and Biologics ProductionThe global protein A resin market size was valued at USD 1,525.00 million in 2024. It is projected to grow from USD 1,620.31 million in 2025 to USD 2,832.54 million by 2034, exhibiting a CAGR of 6.4% during 2025–2034. Market Overview Protein A resins are specialized chromatography media used in the purification of immunoglobulin G (IgG) antibodies, particularly mAbs, by selectively...0 Commenti 0 condivisioni 196 Views 0 Anteprima
-
Stable Cell Line Development Market – Biomanufacturing Platforms Accelerating Biologics ProductionMarket Overview The stable cell line development market is expanding as biomanufacturing platforms accelerate the production of monoclonal antibodies, recombinant proteins, and other biologic therapeutics. Stable cell line development establishes consistent, high-yielding production cell clones essential for reproducible large-scale biologics manufacturing, forming a foundational step in the...0 Commenti 0 condivisioni 226 Views 0 Anteprima
-
The Outsourcing Standard: How Biologics Production Outsourcing is Reshaping the Pharmaceutical IndustryThe biopharmaceutical industry is undergoing a significant transformation, driven by the increasing complexity of drugs and the demand for more efficient and flexible manufacturing models. Biologics production outsourcing has become a strategic imperative for many companies, allowing them to leverage the specialized expertise and infrastructure of contract development and...0 Commenti 0 condivisioni 152 Views 0 Anteprima
-
The Production Standard: How Contract Biologics Manufacturing is Enabling Therapeutic InnovationThe production of biologics—complex drugs derived from living cells—requires specialized facilities, highly skilled personnel, and significant capital investment. Contract biologics manufacturing has emerged as a strategic solution for companies of all sizes, providing access to this critical infrastructure without the burden of building and maintaining it in-house....0 Commenti 0 condivisioni 210 Views 0 Anteprima
-
Veterinary Biologics Market – Vaccine Innovation Protecting Global Livestock ProductionMarket Overview The veterinary biologics market is strengthening as vaccine innovation becomes essential for protecting global livestock production against emerging and re-emerging infectious diseases. Animal agriculture faces constant threats from viral and bacterial pathogens capable of causing devastating economic losses, food supply disruptions, and zoonotic disease transmission risks. The...0 Commenti 0 condivisioni 257 Views 0 Anteprima
-
Cell Culture Media Ingredients Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Cell Culture Media Ingredients Market The global cell culture media ingredients market size was valued at USD 3.76 billion in 2025 and is expected to reach USD 8.73 billion by 2033, at a CAGR of 11.10% during the forecast period This Cell Culture Media Ingredients Market research...0 Commenti 0 condivisioni 8K Views 0 Anteprima
-
Global GMP Cytokines Market: Supporting Cell Therapy and Biopharmaceutical Innovation with High-Quality CytokinesAccording to the latest report published by Data Bridge Market Research, the GMP Cytokines Market CAGR Value The global GMP Cytokines Market was valued at USD 904.38 million in 2024 and is expected to reach USD 1.65 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 9.10%, primarily driven by the rising incidence of chronic diseases...0 Commenti 0 condivisioni 84 Views 0 Anteprima
-
Pharmaceutical Contract Manufacturing Market and Commercial Drug ProductionThe pharmaceutical industry is changing how medicines move from development to commercial production. Instead of building every manufacturing capability internally, drug developers are increasingly relying on specialized external partners to manage production, improve operational efficiency, and respond to evolving treatment requirements. This shift is strengthening the pharmaceutical contract...0 Commenti 0 condivisioni 2 Views 0 Anteprima
-
Protein Expression Market: Regulatory Challenges and Growth OpportunitiesProtein expression has become an increasingly important part of the biotechnology value chain as pharmaceutical and biotechnology companies expand their focus on recombinant proteins, monoclonal antibodies, biosimilars, vaccines, and personalized therapies. Improvements in expression systems are helping researchers produce complex proteins with greater efficiency while supporting faster drug...0 Commenti 0 condivisioni 196 Views 0 Anteprima
-
Why Is the Continuous Bioprocessing Consumables Market Growing Rapidly?Executive Summary Continuous Bioprocessing Consumables Market Size and Share Forecast CAGR Value The global continuous bioprocessing consumables market size was valued at USD 656.88 million in 2025 and is expected to reach USD 1,927.06 million by 2033, at a CAGR of 14.40% during the forecast period Continuous Bioprocessing Consumables Market research report brings into focus the key...0 Commenti 0 condivisioni 787 Views 0 Anteprima
Pagine in Evidenza